[1] Taccone FS,Van den Abeele AM,Bulpa P,et al.Epidemiology of invasive aspergillosis in critically ill patients:clinical presentation,underlying conditions,and outcomes[J].Crit Care,2015,19:7.DOI 10.1186/s13054-014-0722-7.
[2] Liao Y,Chen M,Hartmann T,et al.Epidemiology of opportunistic invasive fungal infections in China:review of literature[J].Chin Med J (Engl),2013,126(2):361-368.
[3] Kosmidis C,Denning DW.The clinical spectrum of pulmonary aspergillosis[J].Thorax,2015,70(3):270-277.
[4] Krijgsheld P,Bleichrodt R,van Veluw GJ,et al.Development in Aspergillus[J].Stud Mycol,2013,74(1):1-29.
[5] Samson RA,Visagie CM,Houbraken J,et al.Phylogeny,identification and nomenclature of the genus Aspergillus[J].Stud Mycol,2014,78:141-173.
[6] Hettick JM,Green BJ,Buskirk AD,et al.Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting[J].Anal Biochem,2008,380(2):276-281.
[7] Ciardo DE,Lucke K,Imhof A,et al.Systematic internal transcribed spacer sequence analysis for identification of clinical mold isolates in diagnostic mycology:a 5-year study[J].J Clin Microbiol,2010,48(8):2809-2813.
[8] Emily WT Tam,Jonathan HK Chen,Eunice CL Lau,et al.Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus:characterization by internal transcribed spacer,β-tubulin,and calmodulin gene sequencing,metabolic fingerprinting,and matrix-assisted laser desorption ionization-time of flight mass spectrometry[J].J Clin Microbiol,2014,52(4):1153-1160.
[9] Schulthess B,Ledermann R,Mouttet F,et al.Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratory[J].J Clin Microbiol,2014,52(8):2797-2803.
[10] Lass-Flörl C.The changing face of epidemiology of invasive fungal disease in Europe[J].Mycoses,2009,52(3):197-205.
[11] Masih A,Singh PK,Kathuria S,et al.Identification by molecular methods and matrix-assisted laser desorption ionization-time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a referral chest hospital in Delhi,India[J].J Clin Microbiol,2016,54(9):2354-2364.
[12] Kontoyiannis DP,Marr KA,Park BJ,et al.Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients,2001-2006:overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database[J].Clin Infect Dis,2010,50(8):1091-1100.
[13] Rittenoura WR,Ciacciob CE,Barnesb CS,et al.Internal transcribed spacer rRNA gene sequencing analysis of fungal diversity in Kansas city indoor environments[J].Environ Sci Process Impacts,2014,16(1):33-43.
[14] Schoch CL,Seifert KA,Huhndorf S,et al.Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi[J].Proc Natl Acad Sci USA,2012,109(16):6241-6246.
[15] Ahmadi B,Mirhendi H,Makimura K,et al.Phylogenetic analysis of dermatophyte species using DNA sequence polymorphism in calmodulin gene[J].Med Mycol,2016,54(5):500-514.
[16] Wang H,Xiao M,Kong F,et al.Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization,and an in vitro antifungal susceptibility study[J].J Clin Microbiol,2011,49(5):1890-1898.
[17] Balajee SA,Houbraken J,Verweij PE,et al.Aspergillus species identification in the clinical setting[J].Stud Mycol,2007,59:39-46.
[18] Frédéric Lamoth.Aspergillus fumigatus-related species in clinical practice[J].Front Microbiol,2016,7:683.DOI 10.3389/fmicb.2016.00683. |